Agree hoofa, although don't know whether i'd go as far to say it's a "roaring buy".
Having now read thru the annual report i'm happier that ddt seem to have turned the corner. Good cash position and low debt. Sales increasing.
The key will be increasing those sales at a greater rate and i'll be very interested to hear more updates in this regard. Obviously concerning if rivals are winning 'dot' business from ddt, particularly in aus, but hopefully the datatrace 'dna' technology is the potential 'company maker' that we are looking for. I've always beleived this to be the case.
Also good to see a stable top 20 shareholder list, and a lot less of the infighting within the board and management.
All in all, a good annual report and they are well positioned for growth. As a long standing and long suffering holder, it's about time....
Cheers, Mac
DDT Price at posting:
4.4¢ Sentiment: LT Buy Disclosure: Held
